Cell Death Induction of Thymidine Kinase Gene Transfer Followed by Ganciclovir Treatment in Oral Squamous Cell Carcinoma Cell Lines by Kuratate, Itaru et al.
Yonago Acta medica 2005;48:63–74
63
Cell Death Induction of Thymidine Kinase Gene Transfer 
Followed by Ganciclovir Treatment in Oral Squamous Cell 
Carcinoma Cell Lines
Itaru Kuratate*†, Mitsuhiko Osaki* and Kazuo Ryoke†
*Division of Organ Pathology, Department of Microbiology and Pathology, †Division 
of Oral and Maxillofacial Biopathological Surgery, Department of Medicine of Sensory 
and Motor Organs, School of Medicine, Tottori University Faculty of Medicine, Yonago 
683-8503 Japan
The tumoricidal effect of herpes simplex virus thymidine kinase (HSV-tk) gene trans-
fer followed by ganciclovir (GCV) treatment has been demonstrated in relation to the 
bystander effect. We examined the mode of cell death after GCV treatment in three 
human oral squamous cell carcinoma (SCC) cell lines that had been infected with ad-
enovirus possessing HSV-tk gene. Oral SCC cell lines displayed high susceptibility to 
HSV-tk/GCV treatment despite low transduction. Evidence suggests that apoptosis was 
not found by internucleosomal DNA fragmentation, cell cycle kinetics or gene expres-
sions indicative of apoptosis.  However, we observed different levels of expression of 
annexin V-positive/propidium iodide-negative cells in all the cell lines and occasional 
TUNEL-positive cells in one cell line. To address these controversial findings, we further 
confirmed the morphological phenotypes of cell death with semi-thin and ultra-thin 
sections, which revealed that the cells undergoing death were consistent with necrosis, 
i.e. swelling of cytoplasm and intracellular organs with membrane disruption.  Further-
more, no apoptotic bodies were detected within cytoplasm of apparently intact cells.  A 
nonapoptotic mechanism may play a central role in the HSV-tk/GCV-induced cell death 
in oral SCC cell lines.
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Squamous cell carcinoma (SCC) is the most fre-
quent malignancy in the oral cavity.  The prognosis 
of advanced oral SCC has remained poor over the 
last few decades despite progress in aggressive ap-
proaches using combination therapy.  Novel strate-
gies should be explored in the oral cancer field.
        One of the potential improvements in cur-
rent therapeutic strategies is herpes simplex virus 
thymidine kinase (HSV-tk) gene transfer fol-
lowed by ganciclovir (GCV) treatment based on 
Abbreviations: Ad, adenovirus; FITC, fluorescein isothiocyanate; GCV, ganciclovir; HSV-tk, herpes simplex virus 
thymidine kinase; IC50, median inhibitory concentration; MOI, multiplicity of infection; PBS, phosphate-buffered 
saline; pfu, plaque forming unit; PI, propidium iodide; SCC, squamous cell carcinoma; TUNEL, terminal deoxy-
nucleotidyl transferase-mediated dUTP-digoxigenin nick-end labeling 
the enzyme/prodrug system concept (Borrelli et 
al., 1988).  HSV-tk-transduced cells selectively 
convert prodrug GCV into monophosphate GCV. 
Triphosphate GCV is the final activated form with 
an ability to kill cells by interfering in DNA syn-
thesis through chain termination and single-strand 
breaks (Elion, 1982).  Another promising aspect of 
this strategy is the existence of the so-called “by-
stander effect” (Freeman et al., 1993; Colombo et 
al., 1995), which mediates cytotoxicity to the adja-
I. Kuratate et al.
64
cent untransduced cells.  There have been two hy-
pothesis proposed to explain the bystander effect: 
(i) transfer of cytotoxic molecules via gap junctions 
because phosphorylated GCV is unable to diffuse 
freely across the cytoplasmic membrane (Bi et al., 
1993) and (ii) phagocytosis of apoptotic bodies con-
taining GCV-metabolites from HSV-tk-transduced 
cells by untransduced intact cells (Freeman et al., 
1993; Colombo et al., 1995).
        HSV-tk/GCV treatment has been successfully 
applied in both human and animal tumor cell lines 
of different origins (Moolten et al., 1990; Glaser 
et al., 2001; Lanuti et al., 1999; Li et al., 1999; 
Boucher et al., 1998). There have been, however, 
few studies on oral SCC cell lines (O’Malley et al., 
1996; Fukui et al., 2001).  While the validity of this 
approach has been confirmed, the molecular mech-
anism of HSV-tk/GCV-induced cell death remains 
to be elucidated.  The most commonly described 
cell death mechanism was related to the induction 
of apoptosis, not only for the execution pathway 
but also the bystander effect (Colombo et al., 1995; 
Samejima and Maruelo, 1995).  On the other hand, 
a few studies have suggested nonapoptotic induc-
tion, i.e. necrosis (Kaneko and Tsukamoto, 1995; 
Vile et al., 1997; Katabi et al., 2002).  Recently, 
activation of caspase-independent apoptotic path-
ways was also suggested because of the incomplete 
inhibition of cell death by caspase inhibitors such 
as z-VAD-fmk (Beltinger et al., 1999; Rivas et 
al., 2001). Both molecular biological analysis and 
morphological examinations are indispensable for 
apoptotic evaluation.  Most studies exposing the 
HSV-tk/GCV-induced cell death mechanism have 
been performed with apoptosis-related molecular 
biological analysis, while a few studies using ultra-
thin examinations have been performed where 
apoptosis was originally evaluated from the mor-
phological changes that occurred at ultra-structural 
levels (Kerr et al., 1972).
        The purpose of the present study was to as-
sess the feasibility of adenovirus-mediated HSV-
tk gene transfer followed by GCV to oral SCC cell 
lines, in addition to verifying whether apoptotic re-
sponses are associated with HSV-tk/GCV-induced 
cell death.  In addition, we examined the ultra-
structural level alterations to identify molecular 
biological changes. 
Materials and Methods
Cell lines
Three cell lines derived from human tongue SCCs 
were used (Table 1).  We obtained HSC-3 and 
HSC-4 from the Health Science Research Resourc-
es Bank (Osaka, Japan), and SCCKN from Riken 
Gene Bank (Tsukuba, Japan).  Cell line 293 derived 
from human embryonic kidney was used for both 
virus purification and titer determination.  All cell 
lines were grown in Dulbecco’s MEM (COSMO 
BIO, Tokyo, Japan) complemented with 1/100 di-
luted Gibco solution (29.2 mg/mL L -glutamine 
10,000 unit/mL penicillin G, 10,000 µg/mL strep-
tomycin) and 10% inactivated fetal bovine serum 
and maintained at 37˚C in an incubator under 5% 
CO2/95% air atmosphere.
Adenovirus vectors
Two replication-deficient recombinant adenovi-
ruses containing LacZ marker gene (Ad.β -gal) as 
a control and luciferase vector, and adenoviruses 
containing HSV-tk (Ad.tk) as the therapeutic vec-
tor under the control of cytomegalovirus promoter 
Table 1. Oral squamous cell carcinoma cell lines and p53 status
 Cell line Histology* p53 status  Mutation  Site mutation codon  
 HSC-3   por mutant  exon8 TAAG insersion (305 and 306)
 HSC-4  well mutant  exon7  248CGC to CAG
 SCCKN mod mutant  exon5  178CAC to -AC (frame shift)
*well, well differentiated type; mod, moderately differentiated type; por, poorly differentiated type.
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were kindly provided from Professor Kenzo Sato 
(Division of Molecular Biology, Department of Mo-
lecular and Cellular Biology, School of Medicine, 
Tottori University Faculty of Medicine, Yonago, 
Japan).  The Ad.β -gal and Ad.tk were propagated 
in 293 cells, which include the Ad5 E1 region in 
chromosomal DNA.  These viruses were purified 
by sequential centrifugation in CsCl step gradients. 
Virus titers were determined as plaque forming 
units (pfu) using a modified end-point cytopathic 
effect assay.  The titers of stock in 5% glycerol and 
95% culture medium of Ad.β -gal and Ad.tk were 
2.27 × 1010 pfu/mL and 1.35 × 1011 pfu/mL, respec-
tively.
 
Adenovirus infection efficiency
Cells were seeded in 24-well culture plates at a 
density of 2 × 104 /well.  After overnight incuba-
tion, stock Ad.β -gal was diluted in 100 µL of 
medium and added at varying multiplicities of in-
fection (MOIs) of 0, 6.25, 12.5, 25, 50 or 100.  The 
cells were exposed for 1 h with constant agitation, 
and then the fresh medium was added up to 500 
µL. Plates were incubated for an additional 24, 48 
and 72 h at 37˚C.  After rinsing with phosphate-
buffered saline (PBS) twice, cells were fixed with a 
solution of 2% formaldehyde and 0.2% glutaralde-
hyde in PBS for 10 min at 4˚C.  Cells were rinsed 
with PBS twice and incubated in a solution contain-
ing the X-gal (0.2% 5-bromo-4-chloro-3-indolyl-
β -D -galactopyranoside) for 4 h at 37˚C.  The num-
ber of blue cells expressing transgene was counted. 
Adenovirus infection efficiency was expressed as a 
mean of the percentage of stained cells to the total 
cells from three randomly selected microscopic 
fields at ×200 magnification.
 
Cell viability assay
Cells were seeded in 60 mm dishes at a density 
of 3 × 105/dish.  After overnight incubation, both 
stock Ad.β -gal and Ad.tk were diluted in 100 µL of 
medium and adjusted at MOIs of 1.25, 5, 10 and 20. 
Each dish was exposed for 1 h with viral diluted 
medium or condition medium, and then fresh me-
dium was added up to 300 µL. After 16 h incuba-
tion at 37˚C, cells were trypsinized and replated in 
96-well culture plates at a density of 3 × 103/well. 
After overnight incubation, the medium was re-
placed with selective 100 µL medium containing 
different concentrations of GCV (0–1,000 µg/mL). 
Uninfected cells without GCV treatment were also 
incubated as controls. Cell viability was assessed 
at 96 h after GCV treatment using an MTT assay 
(CellTiter 96 Nonradioactive Cell Proliferation 
Assay, Promega, Madison, WI).  According to the 
manufacturer’s instruction, 15 µL of the dye solu-
tion was added to each well and the plates were 
incubated for 4 h.  Subsequently, 100 µL of the 
solubilizing solution was added. After overnight in-
cubation, the absorbance at 570 nm wavelength was 
measured using a microplate reader. Cell viability 
was expressed as the relative percentage to control. 
The result represents the mean ± SE of triplicates.
 
DNA fragmentation
 
Both floating and attached cells were harvested 
from wells at 0, 12, 24, 48 and 72 h incubation 
times after HSV-tk/GCV treatment. Cells were 
incubated for 10 min at 4˚C in 100 µL lysis buf-
fer containing 10 mM Tris-HCl (pH 7.4), 10 mM 
EDTA and 0.5% Triton X-100.  After centrifuga-
tion for 5 min at 16,000 rpm, the supernatants were 
decanted and digested with RNase A (100 µg/mL, 
final) at 37˚C for 1 h and then with proteinase K 
(200 µg/mL, final) for 1 h at 37˚C.  After these 
treatments, DNA was extracted by phenol, and 
isopropanol precipitation. These preparations were 
subjected to electrophoresis in 2% agarose gels and 
stained with 0.5 µg/mL ethidium bromide and elec-
trophoretic patterns of the gel under UV light was 
photographed.
 
Cell cycle kinetics 
 
Cells were infected with Ad.tk at MOIs of 5 for 
HSC-3 or 2.5 for HSC-4 and SCCKN, respectively. 
After 16 h incubation, the medium was exchanged 
with GCV medium at a concentration of 1 µg/mL. 
Both floating and attached cells were harvested 
from wells at 0, 12, 24, 48 and 72 h incubation times 
after HSV-tk/GCV treatment. Then, 1 × 106 /mL 
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suspensions were prepared for flow cytometry assay.
        To analyze cell cycle kinetics, 2 × 105 cells 
were fixed in 70% ethanol and stored at 4˚C until 
ready for use.  Cells were centrifuged and resus-
pended in 1 mL PBS containing RNaseA (DNase 
free, 0.1 mg/mL), and stained with 50 µg/mL prop-
idium iodide (PI). Samples were analyzed within 1 
h after the staining procedure.  Fluorescence inten-
sity was determined by an EPICS XL flow cytom-
eter (Coulter, FL).
 
Annexin V assay
 
To detect the early stage of apoptosis, annexin 
V-fluorescine isothiocyanate (FITC) and PI double 
staining were performed according to the manufac-
turer’s instructions for the apoptosis detection kit 
(Trevigen, MD). Briefly, 1 × 105 cells were exposed 
with 100 µL of labeling reagent containinig 1 µL 
of annexin V-FITC conjugate and 10 µL of PI (50 
µg/mL).  After 15 min incubation at room tem-
perature in the dark, an additional 400 µL of 1 × 
binding buffer was added.  Samples were analyzed 
within 1 h after the staining procedure.  Sample 
analysis was also performed using an EPICS XL 
flow cytometer.
 
Antibodies
The following antibodies were used for Western 
blotting; anti-P53 (BP53-12, diluted 1:500; Novo-
castra Lab., Claremont Place, United Kingdom), 
anti-Bax (P-19, 1:250; Santa Cruz Biotechnology, 
Santa Cruz, CA), anti-Bcl-2 (100, 1:250; Santa 
Cruz Biotechnology, Santa Cruz, CA), anti-cas-
pase-3 (CCP32, 1:250; Transduction Laboratories, 
Lexington, KY) and anti-β -actin (Ab-1,1:1500; 
SIGMA, St. Louis, MO).  
 
Expression of apoptosis related protein
 
Both floating and attached cells were harvested 
from wells at 0, 12, 24, 48 and 72 h incubation 
times after HSV-tk/GCV treatment, and solubi-
lized in lysis buffer with 50 mM Tris-HCl (pH 7.4), 
125 mM NaCl, 0.1% NP-40, 1 mM phenyl methyl 
sulfonyl fluoride, 1 ng/mL leupeptin, 10 ng/mL 
soy bean trypsin inhibitor, 1 ng/mL aprotinin, 10 
ng/mL N-tosyl-L-phenylalanyl chloromethyl ketone 
for 1 h on ice.  Lysates were centrifuged at 15,000 
rpm for 10 min and then supernatants were decant-
ed.  Protein concentrations were determined using 
the Bradford protein assay (Bio-Rad Lab., Rich-
mond, CA).  Equal amounts (25 µg) of total protein 
were loaded onto each lane of 10% SDS polyacryl-
amide gels, electrotransferred to a polyvinylidene 
difluoride membrane (Millipore, Bedford, MA), 
and then probed with the respective antibodies. 
Blots were developed with peroxidase-labeled anti-
mouse or anti-rabbit antibodies (1:2000; MBL, Na-
goya, Japan) using enhanced chemiluminescence 
(ECL detection system; Amersham, Bucks, United 
Kingdom).
 
TUNEL method  
 
Cells cultured on cover slips were transduced and 
incubated for 24, 48 and 72 h with and without 
GCV (1 µg/mL).  After incubation, attached cells 
were washed with PBS twice.  Terminal deoxynu-
cleotidyl transferase-mediated dUTP-digoxigenin 
nick-end labeling (TUNEL) staining was per-
formed according to kit protocol with minor modi-
fication using an Apop Tag Plus peroxidase In Situ 
Apoptosis Detection Kit (Intergen, Purchase, NY). 
Briefly, after fixation with 95% ethanol, cells were 
exposed to terminal deoxynucleotidyl transferase 
with digoxigenin-11-dUTP and dATP in a moist 
chamber for 90 min at 37˚C.  Antidigoxigenin 
antibody-peroxidase was used for detection of 
digoxigenin-11-dUTP labeling for 30 min at room 
temperature, followed by color development with 
3,3'-diaminobenzidine containing H2O2 solution. 
Methyl green was used for counterstaining.
 
Morphological examinations  
 
Both floating and attached cells were harvested 
from wells at 72 h with and without GCV (1 
µg/mL) in all cell lines.  After centrifugation and 
washing with PBS twice, cell pellets were fixed in 
Kalnovsky solution for 4 h at 4˚C.  After overnight 
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washing with 0.1 M phosphate solution buffered 
at pH 7.4 at 4˚C, cell pellets were postfixed in 1% 
osmium tetroxide solution for 2 h.  After washing 
with 0.1 M phosphate solution buffered at pH 7.4, 
cell pellets were dehydrated in a graded ethanol 
series and embedded in Epon 812.  After polym-
erization, 1 µm semi-thin sections were served 
for light microscopic examinations after toluidine 
blue staning. Then 60 nm ultra-thin sections were 
served for electron microscopic examination after 
uranyl acetate and Reynold’s lead citrate staining. 
Specimens were examined with an H-800 electron 
microscope (Hitachi, Tokyo).
  
 
Results
 
Adenovirus infection efficiency
 
Adenovirus infecction efficiencies in human oral 
SCC cell lines were quantified using direct cell 
counting with X-gal staining.  We assessed the in-
fection efficiency at the 48 h time point, when the 
β -gal expression level was sufficient.  For 100% 
infection, an MOI 50 was needed for HSC-3 and 
SCCKN cell lines, and impossible for the HSC-4 
cell line within an MOI 100 (Fig. 1).  However, in-
Fig. 1. Adenovirus infection efficiency in oral SCC 
cell lines. Cells were infected with Ad.β -gal at varying 
MOIs of 0, 6.25, 12.5, 25, 50 or 100 pfu/cell, respec-
tively.  At 48 h after the infection, cells were fixed and 
stained by X-gal.  The percentages of cells expressing 
the transgene were counted.  Infection efficiency was 
expressed by the percent average of blue-staining cells 
in three randomly selected × 200 microscopic fields.  , 
HSC-3, , HSC-4 and , SCCKN.
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Fig. 2. Cell viabilities after HSV-tk/GCV treatment. 
Infected cells with either Ad.tk or Ad.β -gal were treated 
with GCV at concentrations ranging from 0 to 1,000 
µg/mL.  Uninfected cells without GCV treatment were 
used as control.  Cell viabilities were measured at 96 
h after GCV treatment using the MTT assay.  Results 
were calculated as the percentage of viability relative to 
control.  The result represents the mean ± SE of tripli-
cates. The IC50 were determined. (a) HSC-3, (b) HSC-4 
and (c) SCCKN cell lines.  , GCV alone; , Ad.β -gal 
+ GCV; , Ad.tk 1.25 MOI + GCV; , Ad.tk5 MOI + 
GCV; ,  Ad.tk 10 MOI + GCV and , Ad.tk 20 MOI + 
GCV. 
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fection of Ad.tk at these high titers failed to be cy-
totoxic to oral SCC cell lines.  Then we performed 
an MOI escalation study to determine the sublethal 
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MOI value of Ad.tk infection (data not shown). 
The results showed MOIs of 20 and less for the 
HSC-3 cell line and 2.5 and less for HSC-4 and 
SCCKN cell lines, respectively. 
 
Cell viability 
 
Cell viability was determined from the colorimetric 
quantity of viable cells.  HSV-tk gene transfer de-
creased the median inhibitory concentration (IC50) 
at least 2 logs lower in all cell lines (Fig. 2).  Cell 
viability was dependent on GCV concentration. 
As the HSC-3 cell line only had resistance to Ad-
tk infection, we could examine cell viabilities at 
several ranges of MOI (Fig. 2a). Though the IC50 
decreased in proportion to the MOI escalation, the 
results were not different between MOIs of 20 and 
10.  This fact suggested the upper limit bounds of 
MOI escalation of this strategy.
 
DNA fragmentation
 
Internucleosomal DNA fragmentation was exam-
ined for standard apoptotic hallmarks.  They all 
showed smearing, whose peaks were 72 h, 72 h and 
24 h for cell lines HSC-3, HSC-4 and SCCKN, re-
spectively (Fig. 3).
Fig. 4. Cell cycle kinetics analysis by flow cytometry.  Cells were infected with Ad.tk at MOI 5 for HSC-3, 2.5 for 
HSC-4 and SCCKN, and followed by 1 µg/mL GCV.  Cells were harvested in a time-dependent manner.  Uninfected 
cells without GCV treatment were used as control.  The number within each panel shows the percentage of Sub-G1 
fractions.  C, control.
Fig. 3. DNA fragmentation after HSV-tk/GCV treat-
ment. Cells were infected with Ad.tk at MOI 5 for 
HSC-3, 2.5 for HSC-4 and SCCKN, and followed by 1 
µg/mL GCV.  Cells were harvested in a time-dependent 
manner.  Uninfected cells without GCV treatment were 
used as control.  DNA extracts were loaded on 2% 
agarose gel by electrophoresis and visualized by stain-
ing with 0.5 µg/mL ethidium bromide.  (a) HSC-3, (b) 
HSC-4 and (c) SCCKN cell lines.  M, marker; C, con-
trol.
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Cell cycle kinetics 
 
Figure 4 shows the results of cell cycle kinetic 
analysis.  The cells broke down severely showing 
a time-dependent decrease of G1 and G2/M peaks 
without cell cycle arrest.  Sub-G1 fraction, which 
means hypodiploid cells correspond to dead cells, 
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Fig. 5.  Annexin V-FITC and PI double stainning by flow cytometry.  Cells were infected with Ad.tk at MOI 5 for 
HSC-3, 2.5 for HSC-4 and SCCKN, and followed by 1 µg/mL GCV.  Cells were harvested in a time-dependent 
manner.  Uninfected cells without GCV treatment were used as control. 
   a:  Representative results of HSC-4.  The number within each panel shows the percentage of each quadrant.  C, control. 
   b:  Increases in percentage in the lower right quadrant relative to control.  , HSC-3, , HSC-4 and , SCCKN. 
   c:  Increases in percentage in the upper right quadrant relative to control.  , HSC-3, , HSC-4 and , SCCKN.
�� �
increased in a time-dependent manner in all the 
cell lines. 
 
Annexin V assay
     
Annexin V has an affinity for the phosphatidylser-
ine that is translocated from the inner leaflet to the 
outer leaflet of the plasma membrane in the early 
stage of apoptosis (Martin et al., 1995).  During the 
late stage, the plasma membrane showed increased 
permeability and PI entered the cytoplasm and 
stained chromatin indicating necrosis.  Figure 5a 
shows representative kinetics of HSC-4 in the cell 
lines.  The proportion of annexin V-positive/PI-
negative cells in the lower right quadrant shows the 
early stage of apoptosis increased in a time-depen-
dent manner (Fig. 5b).  The proportion of annexin 
V-positive/PI-positive in the upper right quadrant 
shows necrosis also increased in a time-dependent 
manner (Fig. 5c).
   
Expression of apoptosis related protein
 
Protein expression levels of P53, P21, Bax, Bcl-2 
and caspase-3 activation were examined by West-
ern blot analysis (Fig. 6).  P53 was stably expressed 
in HSC-3 and HSC-4 cell lines, and undetectable 
at all time points in the SCCKN cell line.  P21 and 
Bax was consistently expressed at any time points 
in all cell lines.  On the other hand, Bcl-2 slightly 
but steadily increased within 24 h after treatment 
in HSC-3 and SCCKN cell lines.  No caspase-3 
cleavage or activation was observed throughout the 
experiment in any cell lines. 
 
TUNEL method  
 
In situ DNA strand breaks were examined by the 
TUNEL method.  TUNEL-positive cells with 
brown-labeled nuclei were occasionally detected 
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in only the SCCKN cell line infected with Ad.tk 
at MOI 2.5 followed by 1 µg/mL GCV after 24 h 
(Fig. 7).  However, we could not evaluate correctly 
at 48 h and 72 h because most treated SCCKN 
cells had easily come off in the staining procedure. 
However, the untreated SCCKN cells showed no 
TUNEL signal.
 
Morphological examinations
 
There were no significant differences in morpho-
logical findings in both semi-thin and ultra-thin 
sections after HSV-tk/GCV treatment among the 
cell lines.  Semi-thin sections of untreated cells 
showed variations in size and shape and occasion-
ally small vesicles in the cytoplasm with a few mi-
toses (Fig. 8a).  In contrast, a large number of treat-
ed cells became swollen with or without membrane 
disruption, sometimes involving nuclei disruption 
(Fig. 8b).  Cytoplasmic vesicles were markedly 
increased. There were few cells with chromatin ag-
gregation in HSC-4 and SCCKN cell lines.
        Ultra-thin sections revealed intact nuclei, 
intracellular organelles and their membranes in un-
treated cells (Fig. 9a).  Otherwise, a large number 
of treated cells contained enlarged and rounded 
nuclei in which heterochromatin was sparse.  Cyto-
plasmic membranes were also disrupted (Fig. 9b). 
Fig. 7.  TUNEL staining of treated SCCKN 24 h after 
GCV treatment.  Cells were infected with Ad.tk at MOI 
2.5, and followed by 1 µg/mL GCV.  TUNEL-positive 
cells with brown-labeled nuclei are occasionally detect-
ed in only SCCKN cell line (arrows).
Fig. 8.  Semi-thin section micrographs of HSC-4 cells. 
(a) Untreated cells.  Some cells occasionally have small 
vesicles, and some display mitoses.  (b) Treated cells 72 
h after GCV treatment.  Cells were infected with Ad.tk 
at MOI 2.5, and followed by 1 µg/mL GCV.  Cells be-
come swollen and intracytoplasmic vesicles remarkably 
increase.  Few cells show chromatin aggregation (ar-
rows). 
Fig. 6.  Western blot analysis of P53, P21, Bax, Bcl-2 and 
caspase-3 of each cell lines.  Cells were infected with 
Ad.tk at MOI 5 for HSC-3, 2.5 for HSC-4 and SCCKN, 
and followed by 1 µg/mL GCV.  Cells were harvested 
in a time-dependent manner.  Uninfected cells without 
GCV treatment were used as control.  (a) HSC-3, (b) 
HSC-4 and (c) SCCKN cell lines.  C, control. 
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A few cells showing chromatin aggregation to the 
nuclear membranes, also displayed cytoplasmic 
membranes disruption.  Treated cells presented 
structural changes of intracellular organelles in-
volving enlargement of mitochondria with the dis-
appearance of cristae, vesiculation and vacuoliza-
tion of endoplasmic reticulum.  Apoptotic bodies 
were not observed in any of the treated cells.
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Fig. 9.  Ultra-thin section micrograph of HSC-4 cells.  (a) Untreated cells.  (b) Treated cells 72 h after GCV treat-
ment.  Cells were infected with Ad.tk at MOI 2.5, and followed by 1 µg/mL GCV.  A large number of cells contain 
enlarged and rounded nuclei of which hetero chromatin are sparse.  Some of treated cells show chromatin aggrega-
tion.  But their cytoplasmic membranes are still disruptured.  Inset of (b) displays enlargement of mitochondria with 
disappearance of cristae, vesiculation and vacuolization of endoplasmic reticula.  Bars in (a) and (b) = 1 µm.
Discussion
This study clearly demonstrated that HSV-tk/GCV 
treatment showed diverse but obvious sensitivity to 
oral SCC cell lines independent of their histologi-
cal status (Table 1 and Fig. 2).  Oral SCC cell lines 
displayed high susceptibility to HSV-tk/GCV treat-
ment despite low transduction, suggesting possible 
tumoricidal effects even in the case of inability of 
100% gene delivery (Fig. 1).  In the HSC-3 cell 
line, however, HSV-tk/GCV treatment showed the 
upper limit bounds at MOI 10.  As reported previ-
ously, a higher expression of HSV-tk gene may not 
be able to further enhance the tumoricidal effect, 
though a threshold level of HSV-tk gene expression 
is necessary for maximum cell killing (Chen et al., 
1995).
        The tumoricidal mechanism of HSV-tk/GCV 
treatment has focused on exploring the molecu-
lar biological events associated with apoptosis 
(Samejima and Maruelo, 1995; Wei et al., 1998; Ri-
vas et al., 2001).  To date, the most reliable method 
for identifying apoptotic cell death is the detection 
of the occurrence of internucleosomal DNA strand 
breaks (Wyllie, 1980).  Concerning past HSV-
tk/GCV treatment studies, several reported the ex-
istence of DNA laddering (Samejima and Maruelo, 
1995; Wei et al., 1998), but several reported the 
opposite (Kaneko and Tsukamoto, 1995).  It is pos-
sible that the DNA fragmentation assay might not 
detect low levels of apoptosis.  Confirmation of the 
phenotype of dying cells is needed by reference to 
morphology using electron microscopy (Vile et al., 
1997).  In fact, some cases failed to demonstrate 
DNA laddering even when the presence of apop-
totic cells was further confirmed using electron 
microscopy (Freeman et al., 1993; Craperi et al., 
1999).  In the present results, DNA fragmenta-
tion showed unspecific DNA degradation, that is, 
smearing (Fig. 3).  Accordingly, both semi- and 
ultra-thin examinations revealed the phenotype of 
dying cells was necrotic in all cell lines.
        Previous studies of flow cytometry demon-
strated that HSV-tk/GCV treatment caused either 
S- and/or G2/M-phase cell cycle arrest before 
undergoing cell death (Kaneko et al., 1995; Wei 
et al., 1998; Craperi et al., 1999).  The present re-
sults showed cell death progressing with no cell 
cycle arrest (Fig. 4).  The DNA content of sub-G1 
increased in a time-dependent manner.  A rapid 
increase was observed in the HSC-4 cell line at 72 
h (42.7%), in which DNA fragmentation definitely 
showed smearing suggesting no occurrence of reg-
ular DNA double-strand breaks.  Annexin V has 
been used as another biological marker to detect 
the early stage of apoptosis before the occurrence 
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of morphological changes in single cells (Martin 
et al., 1995).  The present results showed that an-
nexin V-positive/PI-negative cells corresponding 
to apoptotic cells, increased in a time-dependent 
manner in all cell lines (Fig. 5b), although further 
semi- and ultra-thin examinations revealed ne-
crotic morphological features.  While the external-
ization of phosphatidylserine during apoptosis has 
been presented, intracellular events have not been 
adequately elucidated.  Although the meaning of 
the annexin V-positive reaction induced by HSV-
tk/GCV treatment is not contested, this phenom-
enon implies the feasibility of inspection and exem-
plification by phagocytic cells (Depraetere, 2000; 
Hanayama et al., 2002).  Changes in the properties 
of their surface membrane would improve the com-
bination with a targeting approach such as immu-
notherapy. 
        Since the tumoricidal effect of HSV-tk/GCV 
treatment is conceivable via DNA damage, the loss 
of function of p53 can develop resistance to apop-
tosis. Li et al. reported, however, the HSV-tk/GCV 
cytotoxic response did not depend on the expres-
sion of a functional p53 (Li et al., 1999; Craperi et 
al., 1999).  Similarly, we demonstrated an obvious 
tumoricidal effect without either p53 or p21 expres-
sion (Figs. 4 and 6).  These results were consistent 
in all cell lines and suggested that p53-dependent 
cell cycle regulation or apoptosis induction may not 
correlate with the tumoricidal effect of HSV-tk/
GCV treatment to oral SCC.  Alternatively, HSV-
tk/GCV treatment might have considerable poten-
tial to oral SCC that highly expresses mutated p53 
in vivo (Naglar et al., 2002) and in vitro (Sakai and 
Tsuchida, 1992).  A previous exogenous p53 trans-
duction study suggested co-expression of p53 did 
not enhance the cytotoxicity of HSV-tk/GCV treat-
ment, although p53 was able to increase amount of 
apoptosis which was markedly less than the total 
cell death in vitro (Xie et al., 1999).
        Dimerization between Bax and Bcl-2 is an 
important factor to direct either death promotion or 
death inhibition.  Bax accumulation was reported 
after GCV exposure in glioma cell lines (Craperi 
et al., 1999).  However, they could not rule out 
the possible occurrence of necrotic cell death.  In 
contrast, over-expression of Bcl-2 inhibited HSV-
tk/GCV-induced activation of caspase and apop-
tosis (Beltinger et al., 2000).  However, no syn-
chronous correlation could be found between the 
expression levels of Bcl-2 family and the sensitivity 
to the oral SCC cell lines.
        No cleavage or activation of caspase-3 was 
detected in oral SCC cell lines.  This suggested 
the existence of an alternative molecular pathway 
responsible for the tumoricidal effect of HSV-tk/
GCV treatment to oral SCC cell lines even though 
the route of cell death is unknown.
        One exception in the present study was an oc-
casional positive TUNEL signal in SCCKN cells 
(Fig. 7).  However, no other evidence of apoptosis 
was detected with other biological assays.  Caution-
ary notes suggested that a positive TUNEL signal 
should not be considered as a specific marker of 
apoptosis because the assay would also suggest 
necrotic cell death (Charriaut-Marlangue and Ben-
Ari, 1995; Grask-kraupp et al., 1995).
        Apoptosis was originally described on the 
basis of the morphological features by electron 
microscopy (Kerr et al., 1972) even though some 
features may also be detectable by light micros-
copy.  Apoptotic bodies including cellular remnants 
should be observed either in the intercellular space 
or within the cytoplasm of intact cells.  A large 
number of treated cells showed disintegration of the 
cell structure involving irregular scattered hetero-
chromatin, swelling of cytoplasm and intracellular 
organelles, and cytoplasmic membrane disruption 
in all cell lines.  Furthermore, intact cells contain-
ing apoptotic bodies that deposit the fragmented 
components from neighboring dead cells were not 
found. Based on the annexin V/PI double staining 
at 72 h, the HSC-4 cell line should include the cells 
of early stage apoptosis of 19.1% (Fig. 5).  How-
ever, we could not find firm evidence of apoptosis 
in semi- and ultra-thin section examinations.  Con-
sequently, apoptosis may not play a central role in 
the tumoricidal mechanism.  The hypothesis that 
the bystander effect is mediated by phagocytosis is 
unacceptable for oral SCC cells in vitro.
        A previous study using Fas ligand demon-
strated an artificial deficiency of caspase-8 resulted 
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in a switch of cell death from apoptosis to necrosis 
in Jurket cell lines (Kawahara et al., 1998).  This 
implies that caspase activation itself was dispens-
able for determining cell death.  Kitanaka and 
Kuchino (1999) suggested the existence of caspase-
independent programmed cell death with necrotic-
like morphology, that can be activated either alone 
or in concert with the caspase-dependent apoptotic 
program.  Differential sensitivity and the type of 
cell death induced by HSV-tk/GCV treatment ap-
pear to be dependent upon cell-type difference, in 
addition to the status of the apoptosis-related gene.
        In summary, we demonstrated that oral SCC 
cell lines exhibited an obvious sensitivity to HSV-
tk/GCV treatment suggesting the presence of a 
p53- and caspase-3-independent death signaling 
pathway.  However, the mechanism and the molec-
ular pathway responsible for HSV-tk/GCV-induced 
cell death are still unknown.  A better understand-
ing of the cell death mechanism is essential to 
establish an appropriate and effective modality in 
future studies. 
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